PhytoGaia to Present Healthy Aging, Liver Health, and Pet Wellness Data at Vitafoods Asia 2026

PhytoGaia, a supplier of palm phytonutrients, will present new clinical findings and product development concepts across its branded ingredient portfolio at Vitafoods Asia 2026, scheduled for September 2–4 at the Queen Sirikit National Convention Center in Bangkok.¹ The company will exhibit at Booth H3-T01, according to an August 19, 2026, press release.

The presentation will center on three branded ingredients: STGaia, a plant squalene and tocotrienol complex; TocoGaia, a full-spectrum tocotrienol/tocopherol complex; and PetGaia, a palm fruit extract for companion animal wellness. STGaia was named Ingredient of the Year for Healthy Aging for the 2025 NutraIngredients-Asia Awards, and PetGaia was named winner of the Pet Ingredient Innovation of the Year category for the 2026 Pet Innovation Awards.

Bryan See, vice president of PhytoGaia, explained the borader strategy for PhytoGaia at the event. “At Vitafoods Asia 2026, we look forward to strengthening strategic partnerships across the Asia-Pacific region with brand owners, formulators and manufacturers, particularly in the growing areas of healthy ageing and longevity, beauty-from-within, liver and metabolic health, and pet wellness,” he stated. “Our objective is not simply to supply ingredients. We provide branded, clinically researched phytonutrients with meaningful scientific and commercial value, working closely with our industry partners to develop unique, differentiated and market-ready products. Ultimately, it is about translating science into effective solutions that deliver meaningful benefits to consumers, their families and their loved one.”

What Will PhytoGaia Present on STGaia?

PhytoGaia said it will share clinical insights supporting STGaia's role in healthy aging and longevity, along with new formulation concepts, as part of what the company describes as an "Outside-In and Inside-Out" approach to visible and non-visible aging.

This follows a July 2025 announcement of a six-month, randomized, double-blind, placebo-controlled trial examining STGaia's effects on telomere preservation and cellular longevity, conducted with Monash University Malaysia in participants ages 50 to 75.² That trial also tracks secondary markers including NAD+/NADH ratio, ATP levels, antioxidant enzyme activity, inflammation markers, and gene expression.

What New Clinical Evidence Is PhytoGaia Sharing on TocoGaia?

PhytoGaia said it will present new clinical findings related to liver health, including research tied to metabolic dysfunction-associated steatotic liver disease and alcohol-associated fatty liver disease.

This adds to a body of tocotrienol research the company has referenced previously, including two 2025 literature reviews published in the International Journal of Molecular Sciences examining tocotrienol's antioxidant and anti-inflammatory mechanisms and its comparison to tocopherol in brain health.^3,4 PhytoGaia has also cited a randomized controlled trial published in Nutrients evaluating a TocoGaia-enriched beverage in older adults, which reported effects on psychological well-being, oxidative stress markers, and genomic stability.⁵

What Is New for PetGaia at the Event?

PhytoGaia said it will share findings from a randomized, placebo-controlled canine study, reporting improvements across several clinically assessed measures of skin and coat health.

"PetGaia was developed with a strong focus on scientific validation, quality and safety," Ariati Aris, PhD, the company's senior scientific affairs specialist, had explained in an earlier news release.⁶ "As the only NASC-approved palm fruits extract ingredient for pet wellness, PetGaia reflects our commitment to meeting the highest standards required by the pet nutrition industry. The completion of this randomized, double-blind, placebo-controlled clinical trial provides important scientific evidence demonstrating the significant potential of PetGaia in supporting companion animal health and wellness.”

What Product Concepts Will Be on Display?

Beyond ingredient science, PhytoGaia said it plans to showcase product development concepts intended to help brands differentiate finished products, including softgel and dropper formats featuring PetGaia; vegetarian softgels, liquid capsules, and functional jellies featuring STGaia; and beauty concepts targeting skin, hair, and healthy aging.

References

1. PhytoGaia. From Healthy Ageing to Pet Wellness: PhytoGaia Unveils New Clinical Insights and Product Innovations to Vitafoods Asia 2026. August 19, 2026. Accessed August 20, 2026.
2. New clinical trial will explore palm-derived STGaia and its impact on healthy aging. Nutritional Outlook. July 24, 2025. Accessed August 20, 2026. https://www.nutritionaloutlook.com/view/new-clinical-trial-will-explore-palm-derived-stgaia-and-its-impact-on-healthy-aging
3. Yunita E, Nasaruddin ML, Ramli NZ, Yahaya MF, Ahmad Damanhuri H. Scoping review: the role of tocotrienol-rich fraction as a potent neuroprotective agent. Int J Mol Sci. 2025;26(16):7691. doi:10.3390/ijms26167691
4. Razali RA, Ngah WZW, Makpol S, Yanagisawa D, Kato T, Tooyama I. Shifting perspectives on the role of tocotrienol vs. tocopherol in brain health: a scoping review. Int J Mol Sci. 2025;26(13):6339. doi:10.3390/ijms26136339
5. Sharif R, Wai MK, Choon OT, Abdul Hafid SR, Lee TY. Tocotrienol-enriched beverage enhances psychological well-being, antioxidant defense, and genomic stability in older adults: a randomized controlled trial. Nutrients. 2025;17(13):2179. doi:10.3390/nu17132179
6. McEvoy E. PetGaia wins Pet Ingredient Innovation of the Year at Pet Innovation Awards 2026. Nutritional Outlook. August 13, 2026. Accessed August 20, 2026. https://www.nutritionaloutlook.com/view/petgaia-wins-pet-ingredient-innovation-of-the-year-pet-innovation-awards-2026